Purus Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $502K | Sell |
20,613
-125
| -0.6% | -$3.04K | 0.17% | 83 |
|
|
2025
Q1 | $431K | Sell |
20,738
-381
| -2% | -$7.91K | 0.18% | 81 |
|
|
2024
Q4 | $497K | Sell |
21,119
-65,801
| -76% | -$1.55M | 0.2% | 74 |
|
|
2024
Q3 | $2.23M | Buy |
86,920
+265
| +0.3% | +$6.78K | 0.94% | 27 |
|
|
2024
Q2 | $2.03M | Sell |
86,655
-1,070
| -1% | -$25.1K | 0.9% | 28 |
|
|
2024
Q1 | $2.52M | Sell |
87,725
-3,534
| -4% | -$102K | 1.25% | 21 |
|
|
2023
Q4 | $2.99M | Sell |
91,259
-5,254
| -5% | -$172K | 1.74% | 17 |
|
|
2023
Q3 | $2.69M | Sell |
96,513
-844
| -0.9% | -$23.5K | 1.82% | 16 |
|
|
2023
Q2 | $3.32M | Buy |
97,357
+1,883
| +2% | +$64.2K | 2.15% | 13 |
|
|
2023
Q1 | $2.87M | Sell |
95,474
-475
| -0.5% | -$14.3K | 2.27% | 13 |
|
|
2022
Q4 | $2.71M | Sell |
95,949
-2,473
| -3% | -$69.8K | 2.46% | 10 |
|
|
2022
Q3 | $3.24M | Sell |
98,422
-2,462
| -2% | -$80.9K | 2.98% | 9 |
|
|
2022
Q2 | $3.18M | Sell |
100,884
-1,368
| -1% | -$43.1K | 2.84% | 11 |
|
|
2022
Q1 | $4.7M | Sell |
102,252
-1,443
| -1% | -$66.3K | 3.25% | 10 |
|
|
2021
Q4 | $6.35M | Sell |
103,695
-10,617
| -9% | -$650K | 3.98% | 5 |
|
|
2021
Q3 | $8.54M | Buy |
114,312
+154
| +0.1% | +$11.5K | 5.9% | 2 |
|
|
2021
Q2 | $10.6M | Buy |
114,158
+1,443
| +1% | +$133K | 7.6% | 2 |
|
|
2021
Q1 | $10M | Sell |
112,715
-514
| -0.5% | -$45.6K | 8.41% | 2 |
|
|
2020
Q4 | $10.6M | Buy |
+113,229
| New | +$10.6M | 9.42% | 2 |
|